ATP gatekeeper of Plasmodium protein kinase may provide the opportunity to develop selective antimalarial drugs with multiple targets

Malaria is one of the most devastating infectious diseases that caused millions of clinical cases annually despite decades of prevention efforts. Recent cases of Plasmodium falciparum resistance against the only remaining class of effective antimalarial (artemisinin) in South East Asia may soon pose...

Full description

Bibliographic Details
Main Authors:	Fauze Mahmud, Ping Chin Lee, Habibah A Wahab, Khairul Mohd Fadzli Mustaffa, Chiuan Herng Leow, Azhar Rasul, Ngit Shin Lai
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Asian Pacific Journal of Tropical Medicine
Subjects:	plasmodium falciparum; protein kinase inhibitor; atp-binding site; antimalarial activity
Online Access:	http://www.apjtm.org/article.asp?issn=1995-7645;year=2020;volume=13;issue=8;spage=350;epage=357;aulast=Mahmud

Internet

http://www.apjtm.org/article.asp?issn=1995-7645;year=2020;volume=13;issue=8;spage=350;epage=357;aulast=Mahmud

ATP gatekeeper of Plasmodium protein kinase may provide the opportunity to develop selective antimalarial drugs with multiple targets

Internet

Similar Items